Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Human muscle stem cells are a population of adult stem/progenitor cells found in skeletal muscle tissue. Also known as satellite cells, they reside in a quiescent state under normal conditions and become activated in response to injury or stress. Once activated, these cells proliferate and differentiate into myoblasts that fuse to form new or repair existing myofibers. Human muscle stem cell therapy is being developed for regenerative medicine applications including the treatment of muscular dystrophies, severe traumatic injuries, age-related sarcopenia, and other degenerative muscular diseases. These therapies may use primary isolated satellite cells from donor tissue or derive them from induced pluripotent stem (iPS) cell sources using specific differentiation protocols[1][2][3][4][6][7]. Preclinical studies have shown that transplanted human muscle stem cells can engraft into damaged muscles of animal models and contribute to functional regeneration[3][7][8]. Clinical trials are ongoing or planned for various indications related to severe injury and genetic disorders such as Duchenne muscular dystrophy[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on human muscle stem cells.